Coronavirus and Patients With Inflammatory Bowel Disease: Management Strategies for the Practicing Clinician

Am J Gastroenterol. 2020 Oct;115(10):1566-1569. doi: 10.14309/ajg.0000000000000817.
No abstract available

MeSH terms

  • Betacoronavirus / immunology*
  • COVID-19
  • COVID-19 Testing
  • Clinical Laboratory Techniques / standards
  • Coronavirus Infections / diagnosis
  • Coronavirus Infections / epidemiology
  • Coronavirus Infections / immunology
  • Coronavirus Infections / prevention & control*
  • Gastroenterology / standards
  • Glucocorticoids / adverse effects
  • Humans
  • Immunocompromised Host
  • Immunosuppressive Agents / adverse effects
  • Infection Control / standards*
  • Inflammatory Bowel Diseases / drug therapy
  • Inflammatory Bowel Diseases / immunology*
  • Pandemics / prevention & control*
  • Pneumonia, Viral / diagnosis
  • Pneumonia, Viral / epidemiology
  • Pneumonia, Viral / immunology
  • Pneumonia, Viral / prevention & control*
  • Practice Guidelines as Topic*
  • SARS-CoV-2

Substances

  • Glucocorticoids
  • Immunosuppressive Agents